Day: March 18, 2026

First regulated European asset manager to structure a strategy spanning DeFi lending, institutional secured lending, RWA yields, and basis arbitrage within a single institutional-grade product,  powered by the Kiln’s Railnet orchestration layer. 18 March 2026 | SAINT HELIER, JerseyCoinShares International Limited (“CoinShares” or “the Group”) (Nasdaq Stockholm: CS; US OTCQX: CNSRF), with an announced merger with Vine Hill Capital Investment Corp (Nasdaq: VCIC), a leading global asset manager specialising in digital assets, today announced a strategic partnership with Kiln, the institutional on-chain yield infrastructure provider. The firm will leverage its Railnet protocol to launch its first on-chain asset management strategy, with Railnet providing the verifiable trust layer for the future of capital allocation....

Technip Energies – Verso EnergyTechnip Energies – Verso EnergyTechnip Energies (PARIS: TE) has signed an agreement with Verso Energy to acquire a minority equity stake in the DEZiR project, a synthetic aviation fuel (“eSAF”) plant located in Rouen, France. This investment demonstrates Technip Energies’ support for this major industrial initiative, which has been selected under the France 2030 program and the European Innovation Fund. Technip Energies will contribute to the DEZiR project through the implementation of its carbon capture solution, Canopy by T.ENTM powered by Shell CANSOLV, to capture biogenic CO2 from nearby industries and enable the utilization of this CO2 for eSAF production. In addition, Rely – Technip Energies’ joint venture with John Cockerill dedicated to Power-to-X solutions – is carrying out the...

NEW YORK, March 18, 2026 (GLOBE NEWSWIRE) — Freedom Holding Corp. (Nasdaq: FRHC), an international fintech group founded by entrepreneur Timur Turlov, announces that Moody’s Ratings has assigned its subsidiary, Freedom Bank Kazakhstan, a long-term deposit rating of Ba3 with a stable outlook. This marks Moody’s first rating of the bank and an important milestone in its development and international recognition. The rating reflects the bank’s solid capitalization, dynamic growth in its customer base and deposit portfolio, and continued development of its retail and digital businesses. Moody’s also highlights the important role of Freedom Bank within the ecosystem of Freedom Holding Corp., which integrates financial and digital services. The stable outlook reflects the agency’s expectation that the bank’s financial performance and...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO. 596/2014 ON MARKET ABUSE, AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AND REGULATION (EU) NO. 596/2014 ON MARKET ABUSE. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN...

RENO, Nev., March 18, 2026 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (“Company” or “Ormat”) announced today that it priced private offerings of $725 million aggregate principal amount of 1.50% Series A Convertible Senior Notes due 2031 (the “Series A Notes”) and $150 million aggregate principal amount of 0.00% Series B Convertible Senior Notes due 2031 (the “Series B Notes” and, together with the Series A Notes, the “Notes”). The size of the offering was increased from the previously announced $750 million total aggregate principal amount ($600 million principal amount of the Series A Notes and $150 million of the Series B Notes). The Notes will only be sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”)....

SOUTH SAN FRANCISCO, Calif., March 17, 2026 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq:CTMX), a leader in the field of masked, conditionally activated biologics, today announced the pricing of an underwritten public offering of 45,990,567 shares of its common stock at a price to the public of $5.30 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,179,245 shares of common stock. The gross proceeds to CytomX from the offering are expected to be $250 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, CytomX granted the underwriters a 30-day option to purchase up to an additional 7,075,471 shares of its common stock at the public offering price, less underwriting discounts and commissions. The closing of the offering is...

MIAMI, March 17, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced the pricing of an underwritten public offering of 19,324,677 shares of its common stock at a public offering price of $3.85 per share, and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 2,753,246 shares of common stock at a public offering price of $3.8499 per pre-funded warrant, which represents the per share public offering price less the $0.0001 per share exercise price for each pre-funded warrant. Gross proceeds from the offering are expected to be approximately $85 million, before deducting underwriting discounts and commissions and...